Theratechnologies Inc T.TH

Will THTX backtrack from these statements??

[longterm56]

Although TXTH has been very tight-lipped (wow, that's an understatement), there are two statements directly from Paul that he has not yet retracted or modified (from what I recall): 

• NASH trial to begin in 3rd quarter
• 20-25% Q/Q growth of revenues from Egrifta & Trogarzo. 

We'll see if he comments on or retracts either of these on Thursday. 

   -LT

[SPCEO1]

They already backtracked last quarter on the sales growth statement. I forget the exact wording but it was something that suggested tepid growth short term and better growth long term. My belief is that the 20-25% projection was made just to support the OO. They knew it was nonsense at the time. So, yes management likely lied to investors about that and then quickly retracted it when Q1's ugly

[palinc2000]

This is from the Q 1 CC,,,,This is not backtracking,,,You must be referring to something else While first quarter sales were relatively flat year-over-year, we believe that the trends for the HIV medicines are moving in the right direction. This can be attributed to the momentum that our commercial and medical teams have built to create a stronger base of patients and physician support. Over the

[SPCEO1]

I don't have time to check the transcript from the Q1 call but Paul said something that very much moderated the sales outlook and did not reassert the 20-25% growth statement from earlier. If you are not reasserting that 20-25% number, and they didn't, you are backtracking.  

[jfm1330]

Wow! Now I learned that the management of the company is likely dishonest. But you still think that the stock of a company likely lying on important financial stuff is undervalued. You are hard to follow... But I finally got it, the stock price is so undervalued because the market cannot trust a management that likely lies on important matters. So if they lied there, why not on oncology potential,

[Bucknelly21]

jfm very much I respect your contribution I have learned so much, but you are wrong on this, no one is asking for lies. The market and investment community looks to a company for confidence in what they are doing and working on. If you don't say anything other that what is public knowledge and a bare minimum you create zero excitement resulting in no one paying attention beside the select few

[SPCEO1]

JFM1330 - you have lost your moorings. Time to calm down a bit and try and see things more accurately.  Let me try and help you do that: 1.) The company stated just before the OO that the legacy drug revenues would grow at 20-25% annually. Immediately after, they stopped saying that and produced a real dud on sales in Q1. I will let you decide how you would like to characterize that but it